Award tenders
Awarded contractNeg Wo CallSuppliesSpain

Suministro de Omalizumab (DOE), Nilotinib (DOE), Eltrombopag (DOE), Dabrafenib (DOE), Secukinumab (DOE), Pazopanib (DOE), Trametinib (DOE), Everolimus (DOE) y Midostaurina (DOE)

1 supplier awarded9 lots awarded€19.20M awarded

Buyer: OSAKIDETZA - Servicio Vasco de Salud - Hospital Universitario Cruces (Impulsora) / Barakaldo, Spain

Published Aug 06, 2024
Pharmaceutical products

Awarded value

€19.20M

Estimated value

€115.21M

Awarded at 17% of estimated value

Award date

Winners

1

Lots awarded

9

Winners

9 lots

€19.2M This contract

18 award notices45 awarded lots€128.54M total

Lots awarded

LotTitleWinnerAward valueMain CPV
LOT-0001
NOVARTIS FARMACEUTICA, SA€4.7M

Pharmaceutical products (33600000)

LOT-0005
NOVARTIS FARMACEUTICA, SA€3.7M

Pharmaceutical products (33600000)

LOT-0003
NOVARTIS FARMACEUTICA, SA€3.0M

Pharmaceutical products (33600000)

LOT-0004
NOVARTIS FARMACEUTICA, SA€2.8M

Pharmaceutical products (33600000)

LOT-0002
NOVARTIS FARMACEUTICA, SA€1.9M

Pharmaceutical products (33600000)

LOT-0006
NOVARTIS FARMACEUTICA, SA€1.7M

Pharmaceutical products (33600000)

LOT-0007
NOVARTIS FARMACEUTICA, SA€1.2M

Pharmaceutical products (33600000)

LOT-0009
NOVARTIS FARMACEUTICA, SA€153,764

Pharmaceutical products (33600000)

LOT-0008
NOVARTIS FARMACEUTICA, SA€79,601

Pharmaceutical products (33600000)